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ABSTRACT 
Mexican Americans (MAs) have been shown to have worse outcomes after stroke than 
non-Hispanic Whites (NHWs), but it is unknown if ethnic differences in stroke quality of 
care may contribute to these worse outcomes. We investigated ethnic differences in the 
quality of inpatient stroke care between MAs and NHWs within the population-based 
prospective Brain Attack Surveillance in Corpus Christi (BASIC) Project (February 
2009- June 2012). Quality measures for inpatient stroke care, based on the 2008 Joint 
Commission Primary Stroke Center definitions were assessed from the medical record by 
a trained abstractor. Two summary measure of overall quality were also created (binary 
measure of defect-free care and the proportion of measures achieved for which the patient 
was eligible). 757 individuals were included (480 MAs and 277 NHWs). MAs were 
younger, more likely to have hypertension and diabetes, and less likely to have atrial 
fibrillation than NHWs. MAs were less likely than NHWs to receive tPA (RR: 0.72, 95% 
confidence interval (CI) 0.52, 0.98), and MAs with atrial fibrillation were less likely to 
receive anticoagulant medications at discharge than NHWs (RR 0.73, 95% CI 0.58, 0.94). 
There were no ethnic differences in the other individual quality measures, or in the two 
summary measures assessing overall quality. In conclusion, there were no ethnic 
differences in the overall quality of stroke care between MAs and NHWs, though ethnic 
differences were seen in the proportion of patients who received tPA and anticoagulant at 
discharge for atrial fibrillation.  
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INTRODUCTION 
 Hispanics are now the largest minority population in the United States, with Mexican 
Americans (MAs) making up the largest sub-population.(United States Census Bureau, 2013) 
MAs have a higher risk of incident and recurrent stroke compared with non-Hispanic Whites 
(NHWs), and also have worse functional outcomes after stroke.(Lisabeth et al., 2014; Lisabeth et 
al., 2006; Morgenstern et al., 2013) Racial and ethnic disparities in stroke quality measures have 
been previously reported, though most studies have focused on differences involving African 
Americans, with relatively few studies specifically focused on Hispanic/Latino 
populations.(Cruz-Flores et al., 2011; Jacobs et al., 2006; Kelly, Hellkamp, Olson, Smith, & 
Schwamm, 2012; Reeves et al., 2010; Schwamm et al., 2010) One study based on the Get with 
the Guidelines (GWTG) database that did separately analyze Hispanics from other race-ethnic 
groups found few overall differences in stroke quality of care between Hispanics and non-
Hispanic whites (NHWs), though Hispanics were less likely to have counseling for smoking 
cessation and discharge anti-thrombotics when adjusted for patient and hospital 
characteristics.(Schwamm et al., 2010) However, it is unknown if these findings are consistent in 
other health systems that do not participate in GWTG, within specific Hispanic sub-populations, 
or when addressed in a community-based study.  
Investigation of potential ethnic differences in quality of care specifically between MAs 
and NHWs is warranted to determine if the observed ethnic differences in outcomes may be due 
to ethnic disparities in quality of stroke care. We investigated ethnic differences in the quality of 
inpatient stroke care in a population-based study in a bi-ethnic community without an academic 
medical center.  
 
METHODS 
Study population and case identification 
This study was a pre-planned cross-sectional analysis from the prospective Brain Attack 
Surveillance in Corpus Christi (BASIC) Project. Detailed study methods have been previously 
reported.(Morgenstern et al., 2013) Briefly, active and passive surveillance were used to identify 
cases of stroke >44 years old presenting to one of six hospitals in Nueces County, Texas. This is 
a predominantly urban, bi-ethnic, non-immigrant community where the majority (62%) of 
residents are of MA descent(United States Census Bureau, 2014) and are second or third 
generation US residents. The six acute care hospitals (median bed size 154, range 72-345) in the 
community all have CT, MRI and neurology services. Two of the hospitals were certified by the 
Joint Commission as Primary Stroke Centers (one in January 2009 and the other in December 
2010). Stroke diagnosis was validated by study physicians using source documentation blinded 
to ethnicity and age. Eligibility criteria for the current study included individuals with ischemic 
stroke presenting between February, 2009 and June, 2012. Ethnicity was determined from the 
medical record as we have previously reported high agreement between medical record and self-
report in this community.(Morgenstern et al., 2004) Only individuals of NHW or MA ethnicity 
were included due to low numbers of individuals in other race-ethnic groups. If an individual had 
multiple events during the study period, only the first ischemic stroke was included. This study 
was approved by the Institutional Review Board of the University of Michigan (approval number 
HUM00041536) as well as the local Corpus Christi hospital systems. Screening the medical 
record for stroke cases was approved under a waiver of informed consent, with written consent 
obtained for detailed medical record review and interviews. 
Medical record review and quality measures 
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Trained abstractors reviewed the medical record for key clinical characteristics. Initial 
National Institutes of Health Stroke Scale (NIHSS) was determined from the medical record or 
abstracted from the chart based on a previously validated method.(L. S. Williams, Yilmaz, & 
Lopez-Yunez, 2000) Highest level of education was assessed based on interview with the patient 
or proxy, as was pre-stroke disability (based on a published structured interview for the Modified 
Rankin Scale.(Wilson et al., 2002)) Health insurance status was determined from medical record 
review. The number of comorbid conditions was determined from the medical record and 
summed to create a comorbidity index for each patient (range 0-15). 
 Stroke quality measures were determined from the medical record by a trained abstractor, 
adapted from the 2008 Joint Commission Primary Stroke Center definitions. Data were collected 
on the following measures: 1) deep vein thrombosis prophylaxis; 2) discharged on 
antithrombotic therapy; 3) patients with atrial fibrillation receiving anticoagulation therapy at 
discharge; 4) thrombolytic therapy administered; 5) antithrombotic therapy by the end of hospital 
day 2; 6) discharged on cholesterol reducing medication; and 7) assessed for rehabilitation. 
Transferred patients had the quality measure attributed to the discharging hospital. Two 
summary measures of the overall quality of care were used.(Peterson et al., 2010) A composite 
opportunity score was created by dividing the number of performance measures that a patient 
met by the number of measures they were eligible for, such that the final score ranged from 0 to 
1. A binary defect-free care variable was defined as a patient meeting all of the eligible 
performance measures.  A reliability study of the individual quality measures was performed by 
having a second abstractor review a sample of 29 cases as described in the Appendix. The mean 
percent agreement was 92% (range 83-100%) for determination of inclusion/exclusion in the 
denominators and 97% (range 88% to 100%) for determination of inclusion/exclusion in the 
numerators.  
Statistical Analysis 
Descriptive statistics were calculated for all variables; differences by ethnicity were 
assessed using chi-square tests for categorical and Kruskal-Wallis tests for continuous variables. 
To examine ethnic differences in quality of care measures, we fit a Poisson model (unadjusted) 
with robust standard errors to report relative risk for the binary outcomes and a linear model 
(unadjusted) with robust standard errors for the continuous composite score. To account for 
hospital clustering, we then used generalized estimating equations (GEE) with a log link function 
for the binary outcomes (Lu & Tilley, 2001) and GEE with the identity link function for the 
continuous outcome, and robust standard errors were additionally corrected for the small number 
of clusters used (n=6 hospitals).(Mancl & DeRouen, 2001) Adjustment for hospital clustering 
was not performed for the tPA and anticoagulant for atrial fibrillation measures due to small 
numbers of eligible participants for these measures at some of the hospitals. In order to assess the 
effect of potential confounders of any observed ethnic differences in the quality measures, we 
sequentially added covariates to the regression models for each of the individual and overall 
quality measures, beginning with an unadjusted model including ethnicity alone (model 1), next 
adding in hospital clustering (model 2, except for tPA and atrial fibrillation measures as noted 
above), and then demographics including age and sex (model 3). To avoid overfitting the model, 
no additional adjustment was performed for the individual quality indicators due to the low 
number of outcome events per variable.(Peduzzi, Concato, Kemper, Holford, & Feinstein, 1996) 
However, for the two overall quality measures where there were a larger number of outcome 
events per variable, a final fully adjusted model (model 4) was developed to additionally adjust 
for education, insurance, pre-stroke disability (Modified Rankin 0-2 versus 3-5), NIHSS, and 
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comorbidity index. To estimate the impact of hospital system on quality, the absolute values for 
the intraclass correlation coefficients (ICC) were calculated from the hierarchical models (i.e., 
model 2) for the two overall quality outcomes. The functional form of continuous covariates 
(age, NIHSS) was assessed. Due to non-linear associations with outcome, age was modeled with 
quadratic term for the composite opportunity score and NIHSS was log transformed and modeled 
with a quadratic term for both overall quality measures. 
 
RESULTS 
A total of 844 individuals with ischemic stroke were identified during the study period, 
with 79 cases excluded for race-ethnicity other than MA or NHW, 5 excluded as not eligible for 
any quality measure, and 3 excluded due to missing covariates (2 for education and 1 for 
comorbidity index), leaving a total of 757 individuals available for analysis. Descriptive 
characteristics and stroke risk factors by ethnicity are shown in Table 1. MAs were younger, 
more likely to have hypertension and diabetes, and less likely to have atrial fibrillation than 
NHWs. Education and insurance were also different by ethnicity. There were no ethnic 
differences in the initial NIHSS, comorbidity index, or in-hospital mortality. 
 
Table 1: Descriptive characteristics of the population overall and by ethnicity  
Characteristic 
Non-Hispanic 
White 
N=277 
(% unless 
specified) 
Mexican 
American 
N=480 
(% unless 
specified) 
Median Age (Q1, Q3) 72 (60, 82) 66 (57,78) 
Female Sex 52.3 51.3 
Hypertension 75.1 85.8 
Diabetes 28.2 59.8 
Prior stroke or TIA 30.7 33.5 
High cholesterol 49.5 45.6 
Atrial fibrillation 21.7 11.0 
CAD or MI  30.0 34.8 
Smoker 45.8 29.0 
Median Comorbidity index (Q1, Q3) 3 (2, 5) 3 (2, 5) 
Median NIHSS (Q1, Q3) 4 (2,10) 4 (2,9) 
Baseline MRS 0-2 76.5 75.2 
In-hospital death 3.6 3.1 
Education 
   Less than High school 
   High school 
   Vocational/some college 
   College or more 
 
13.7 
31.4 
27.8 
27.1 
 
52.7 
26.0 
13.3 
7.9 
Insurance 
    Self pay 
   Medicare, Medicaid and Medicare, 
         or Veterans Affairs 
 
12.3 
15.9 
 
 
16.9 
24.4 
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   Medicaid 
   Private, Private and Medicare 
1.4 
70.4 
3.3 
55.4 
MA indicates Mexican American; NHW, non-Hispanic white; mRS, modified Rankin scale; TIA, transient ischemic 
attack; CAD, coronary artery disease; MI, myocardial infarction; and NIHSS, National Institute for Health Stroke 
Scale.       
 A descriptive summary for the individual quality measures and the two summary quality 
measures by ethnicity are reported in Table 2. Most of the individual measures were met in 80% 
or more of cases; exceptions included DVT prophylaxis (79.0% overall) anticoagulant at 
discharge for atrial fibrillation (70.1% overall), and acute stroke therapy with tPA administered 
(62.2% overall). 
 
Table 2: Quality indicators, overall and by ethnicity 
Quality indicator 
Non-Hispanic 
White (N=277) 
Mexican American 
(N=480) 
N/D or 
median 
% or 
Q1, Q3 
N/D or 
median 
% or 
Q1, Q3 
Deep vein 
thrombosis 
prophylaxis at 48 
hours 
154/195 79.0 261/330 79.1 
Discharged on 
antithrombotic 
211/249 84.7 377/435 86.7 
Anticoagulant at 
discharge for atrial 
fibrillation 
53/66 80.3 36/61 59.0 
tPA administered 27/36 75.0 29/54 53.7 
Antithrombotic at 
48 hours  
228/241 94.6 405/434 93.3 
Cholesterol 
medication at 
discharge 
149/193 77.2 273/331 82.5 
Rehabilitation 
evaluation 
223/229 97.4 389/407 95.6 
Summary measures 
Defect Free Care 161/277 58.1 284/480 59.2 
Median composite 
score (Q1, Q3) 
1.0 (0.8,1.0) 1 (0.8,1.0) 
*N/D indicates Numerator/Denominator, e.g. number of patients attaining the quality measure over the number of 
patients eligible for the quality measure. 
 
The regression models investigating ethnic differences in the individual indicators are shown in 
Table 3. Most of the individual measures did not show differences by ethnicity. However, MAs 
were less likely than NHWs to receive tPA (relative risk (RR) 0.72, 95% confidence interval (CI) 
0.52, 0.98). Similarly, MAs with atrial fibrillation were less likely to receive anticoagulant 
medications at discharge when compared with NHWs (RR 0.73, 95% CI 0.58, 0.94). There were 
no ethnic differences in any of the other individual quality indicators. Note that the sequential 
model building (adding adjustment for hospital clustering when appropriate and then age and 
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sex) did not result in any meaningful changes in the magnitude of the association between 
ethnicity and any of the quality measures. 
 
Table 3: Association of Mexican American ethnicity with individual quality indicators 
Quality indicator 
Model 1: 
Unadjusted 
Model 2: Add 
hospital 
clustering 
Model 3: Add 
age* and sex 
RR for MA† 
(95%CI) 
RR for MA† 
(95% CI) 
RR for MA† 
(95% CI) 
Deep vein thrombosis 
prophylaxis at 48 hours 
1.00 
(0.91, 1.10) 
1.00 
(0.90,1.11) 
1.00 
(0.94, 1.06) 
Discharged on 
antithrombotic 
1.02 
(0.96, 1.09) 
1.02 
(0.88, 1.19) 
1.01 
(0.89, 1.15) 
Anticoagulant at discharge 
for atrial fibrillation‡ 
0.73 
(0.58, 0.94) 
- 
0.74 
(0.58, 0.94) 
tPA administered‡ 
0.72 
(0.52, 0.98) 
- 
0.70 
(0.51, 0.96) 
Antithrombotic at 48 hours  
0.99 
(0.95, 1.03) 
0.99 
(0.96, 1.01) 
0.98 
(0.94, 1.02) 
Cholesterol medication at 
discharge 
1.07 
(0.98, 1.17) 
1.06 
(0.99, 1.13) 
1.05 
(0.97, 1.13) 
Rehabilitation evaluation 
0.98 
(0.95, 1.01) 
0.97 
(0.88, 1.07) 
0.97 
(0.88, 1.08) 
MA indicates Mexican American; RR, Relative Risk; and CI, confidence interval 
*Age was modeled as a linear term.  
†Reference group for Mexican American was non-Hispanic white.   
‡Unable to adjust for hospital clustering due to small sample size for these quality measures, therefore model 3 
includes only age, ethnicity, and sex as covariates. 
 
The findings for the regression models for the two overall summary indicators are shown 
in Table 4. The absolute values for ICC for the hospital effect were < 0.01 for both the composite 
score and defect-free care, suggesting that there was little difference in quality across hospitals. 
For the composite quality score, ethnicity was not associated with quality in the unadjusted or 
adjusted models. Factors significantly associated with better quality of care in the fully-adjusted 
composite model included younger age, male sex, insurance, education, baseline modified 
Rankin of 0-2, and stroke severity. For the defect-free care measure, there was also no ethnic 
difference in quality in either the unadjusted or fully adjusted models. Factors associated with 
defect free care in the fully-adjusted model included younger age, male sex, lower comorbidity 
index, insurance, education, and stroke severity.  
 
Table 4: Overall quality of care measures by ethnicity  
 Model 1* Model 2† Model 3‡ Model 4§ 
 
Estimate or RR 
(95%CI) 
Estimate or RR 
(95%CI) 
Estimate or RR 
(95%CI) 
Estimate or RR 
(95%CI) 
Composite Quality Score 
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Estimate 
for MA 
-0.004  
(-0.034, 0.026) 
-0.003 
(-0.034, 0.028) 
-0.01 
(-0.026, 0.005) 
-0.016 
(-0.064, 0.032) 
Defect Free Care 
RR for 
MA 
1.01 
(0.94, 1.09) 
1.02 
(0.82, 1.27) 
0.99 
(0.90, 1.10) 
0.97 
(0.86, 1.09) 
MA indicates Mexican American; RR, Relative Risk; and CI, confidence interval.  
Reference group for Mexican American was non-Hispanic white.   
*Model 1: Unadjusted (ethnicity alone) 
†Model 2: Add hospital clustering  
‡Model 3: Add in age (linear term for the defect free and quadratic term for the composite score), and sex 
§Model 4: Add education, insurance, pre-stroke disability (Modified Rankin 0-2 versus 3-5), National Institutes of 
Health Stroke Scale (log transformed and quadratic), and comorbidity index 
 
DISCUSSION 
 We found no difference in the overall quality of stroke care provided between MAs and 
NHWs in this community using a measure of defect free care and a composite quality score. 
However, there were differences in some of the individual quality indictors, with MAs less likely 
than NHWs to receive intravenous tPA and to receive anticoagulant medications at discharge in 
the setting of atrial fibrillation. While the lack of difference in overall quality is reassuring, it is 
concerning that the magnitude of the ethnic differences seen in the tPA and discharge 
anticoagulant measures was quite large, with MAs about 30% less likely than NHWs to meet 
these measures. While the differences in tPA and discharge anticoagulant are potentially 
important and could contribute to health disparities between MAs and NHWs,(Lisabeth et al., 
2014; Lisabeth et al., 2006) it seems unlikely that these two quality measures would entirely 
explain the observed ethnic differences in functional outcome and stroke recurrence, as less than 
20% of patients were eligible for each of these measures.  
 There are a limited number of prior studies that have investigated the quality of stroke 
care among Hispanics.(Cruz-Flores et al., 2011) The largest study that specifically compared 
quality of care between Hispanics and NHWs was based on the GWTG data.(Schwamm et al., 
2010) Our study differs from the in the GWTG dataset as it is a population-based sample from a 
community with a large, non-immigrant MA population. Similar to our study, the GWTG 
investigators found no difference in the overall quality of care between Hispanics and NHWs 
using a defect-free care measure. They did identify some statistically significant, but small 
absolute ethnic differences in individual quality indicators, with Hispanics less likely to receive 
discharge antithrombotics and smoking cessation counseling, but no differences were seen in 
other measures including tPA and anticoagulation for atrial fibrillation.(Schwamm et al., 2010) 
Our study adds to this prior work by specifically focusing on MAs, the largest sub-population of 
Hispanics, and identifies several areas of potentially large ethnic disparities in quality of stroke 
care in this community.  
Examining the issue of discharge anticoagulant for atrial fibrillation in more detail, a 
prior study of nursing home residents found that Hispanics with stroke and an indication for 
anticoagulation were less likely than NHWs to receive warfarin, though this difference was 
attenuated when adjusting for demographics and other risk factors.(Christian, Lapane, & Toppa, 
2003) In BASIC, we have previously reported that MAs are more likely than NHWs to have a 
recurrent stroke in the setting of atrial fibrillation, and that the recurrent strokes tended to be 
more severe among MAs.(Simpson et al., 2010) This prior analysis did not identify any ethnic 
difference in the proportion of patients discharged on warfarin, though the use of warfarin at 
discharge was low in both ethnic groups (<40%). The prior analysis was based on an earlier time 
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period (2000-2008) and had other minor methodological differences that complicate a direct 
comparison of results, though these two analyses suggest a worrisome pattern of disparities in 
the care of MA stroke patients with atrial fibrillation. This disparity is likely to be of increasing 
importance given the growing population of older MAs.(Vincent & Velkoff, 2010) 
Our findings on the tPA and discharge anticoagulant measures should be interpreted with 
a degree of caution, as these two indicators had the smallest number of eligible individuals (90 
for tPA and 127 for discharge anticoagulant) compared with other quality indicators, and 
therefore our ability to adjust for confounders was limited. Since these quality measures are 
designed by definition to identify only individuals eligible for the particular therapy, the 
unadjusted result is arguably the more important finding than the adjusted result, and it is the 
unadjusted raw proportion that is subject to public reporting of hospital outcomes. Therefore, 
identifying potential confounders of the ethnicity-quality relationship is useful to explain the 
reason for the disparity, but does not diminish the importance of the observed unadjusted ethnic 
difference in quality. Still, given the relatively small sample, further confirmation of these 
findings in other populations is warranted.  
Other studies have suggested that hospital differences may be an important determinant 
of variability in quality of care.(Reeves et al., 2010; Schwamm et al., 2010) We found no 
evidence of an effect of hospital-level differences in quality of care in this community, as the 
hospital level ICC was quite small for the two overall quality measures. It is worth noting that 
the majority of cases in this study came from a single hospital, which may have limited our 
ability to detect hospital-level differences. Additionally, this is a smaller community relative to 
other reports (6 hospitals), and therefore quality may be more homogenous within the 
community. Two of the six hospitals in this community are certified as primary stroke centers, 
with one obtaining certification in January 2009 and the other in December 2010. Since our data 
collection started in February 2009, we did not formally investigate the effect of stroke center 
certification on quality due to low number of pre-certification cases available in these hospitals. 
This study has limitations. While the quality measures were based on 2008 JC measures, 
minor adaptations to the quality measures were needed for the current study. As with any process 
measure, we cannot be certain if these differences are due to a true difference in treatment versus 
simply an artifact of differences in documentation of care. However, accurate documentation is 
one important dimension of quality, especially now with public reporting of stroke quality 
measures.  
 
CONCLUSION 
MAs were less likely than NHWs to receive certain recommended stroke treatments 
including intravenous tPA and anticoagulant medication at discharge for atrial fibrillation. While 
there was no ethnic difference in the overall quality of care provided, further investigation of 
these particular measures where larger differences were identified is warranted in order to design 
interventions to eliminate these disparities.  
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APPENDIX: RELIABILITY OF QUALITY MEASURES 
A random sample of thirty stroke cases for the time period 2011-2012 was selected for 
the reliability study. One case was ineligible due to a change in validation status leaving 29 cases 
eligible for the reliability study. Data elements for all quality measures were re-abstracted from 
the medical record by a second abstractor blinded to the prior assessment and compared to the 
original data. Reliability was considered in two ways following methods previously published 
for assessing the reliability of standardized performance measures.(S. C. Williams, Watt, 
Schmaltz, Koss, & Loeb, 2006) First, agreement was assessed for determination of whether a 
patient was included or excluded from the denominator for each quality measure (i.e., the quality 
measure population). Second, agreement was assessed for determination of whether a patient was 
included or excluded from the numerator for each quality measure, given that both raters 
included the patient in the denominator for that measure. Agreement was calculated as percent 
agreement, percent positive agreement, and percent negative agreement using the formulas 
outlined below.(Cicchetti & Feinstein, 1990) Kappa was not calculated given the imbalance in 
the marginal totals of the two by two tables for the quality measures which has been shown to 
result in artificially low estimates of kappa despite high agreement.(Cicchetti & Feinstein, 1990)    
 
Proportion of positive agreement 2*a/(N+a-d) 
In 2X2 table, a, b, c, d  
represent frequency of  
each cell 
Proportion of negative agreement 2*d/(N-a+d) a b   
Proportion of observed agreement (a+d)/N c d   
     N = a+b+c+d 
 
 
Results of the reliability study are included in Appendix Table 1 (denominators) and Appendix 
Table 2 (numerators). Percent agreement for determination of whether patients were 
included/excluded from the denominator for the quality measures ranged from 83% for deep vein 
thrombosis (DVT) prophylaxis to 100% for thrombolytic therapy administered (tPA). Percent 
agreement for determination of whether patients were included/excluded from the numerator for 
the quality measures ranged from 88% for antithrombotic at discharger to 100% for several of 
the measures (DVT prophylaxis, discharged on cholesterol reducing medication, patients with 
atrial fibrillation receiving anticoagulation therapy at discharge, tPA). 
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Appendix Table 1: Comparison of originally abstracted and re-abstracted data for determination 
of inclusion/exclusion in the denominator of the quality measure. 
    
Re-
abstracted  
data   
Quality measure 
Original  
data 
Yes No 
Observed 
proportion 
of 
agreement 
Proportion 
of positive 
agreement 
Proportion 
of negative 
agreement 
DVT prophylaxis 
at 48 hours 
Yes 20 5 
0.83 0.89 0.62 
No 0 4 
Discharged on 
antithrombotic 
Yes 24 1 
0.90 0.94 0.57 
No 2 2 
Anticoagulant at 
discharge for afib 
Yes 4 0 
0.97 0.89 0.98 
No 1 24 
tPA administered  Yes 4 0 
1.00 1.00 1.00 
No 0 25 
Antithrombotic at 
48 hours  
Yes 26 2 
0.93 0.96 0.50 
No 0 1 
Cholesterol 
medication at 
discharge  
Yes 16 1 
0.93 0.94 0.92 
No 1 11 
Rehabilitation 
evaluation 
Yes 24 3 
0.90 0.94 0.57 
No 0 2 
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Appendix Table 2: Comparison of originally abstracted and re-abstracted data for determination 
of inclusion/exclusion in the numerator* of the quality measure. 
    
Re-
abstracted  
data   
Quality measure 
Original 
data 
Yes No 
Observed 
proportion 
of 
agreement 
Proportion 
of positive 
agreement 
Proportion 
of negative 
agreement 
DVT prophylaxis 
at 48 hours  
Yes 18 0 
1.00 1.00 1.00 No 0 2 
Discharged on 
antithrombotic  
Yes 18 1 
0.96 0.97 0.91 No 0 5 
Anticoagulant at 
discharge for afib  
Yes 4 0 
1.00 1.00 0.00 No 0 0 
tPA administered  Yes 4 0 
1.00 1.00 0.00 No 0 0 
Antithrombotic at 
48 hours  
Yes 21 2 
0.88 0.93 0.57 No 1 2 
Cholesterol 
medication at 
discharge  
Yes 15 0 
1.00 1.00 1.00 No 0 1 
Rehabilitation 
evaluation  
Yes 23 1 
0.96 0.98 0.00 No 0 0 
*Agreement statistics for numerator were calculated when both raters included the record in the indicator population. 
 
 
